AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26094330 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with inflammatory bowel diseases and Control group
Number of subjects: 16
Study 24041231 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU and telephone monitoring and counseling (TMC)
Number of subjects: 321
Study 24041231 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU and TMC plus incentives (TMC+)
Number of subjects: 321
Study 24041231 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 321
Study 20952244 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-modal treatment program (MMT) including heat, Van den Akker manual therapy, stretching, and a return to running program.
Number of subjects: 0
Study 20952244 — intervention group
Group type: COMPARATOR
Intervention: Exercise therapy (ET) including a home-based ET and a structured return to running program with instruction from a sports physical therapist.
Number of subjects: 0
Study 20952244 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MMT and ET
Number of subjects: 0
Study 18647656 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP)
Number of subjects: 63
Study 18647656 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (Mk)
Number of subjects: 63
Study 18647656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 16535795 — intervention group
Group type: EXPERIMENTAL
Intervention: ActivSkin therapy group
Number of subjects: 9
Study 16535795 — intervention group
Group type: COMPARATOR
Intervention: Control group (vash oil gauze)
Number of subjects: 9
Study 14528620 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 10764174 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 49
Study 10764174 — intervention group
Group type: COMPARATOR
Intervention: Facemask and Oral Airway (FM‐OA)
Number of subjects: 49
Study 8836300 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe hypoglycemia group (SH group)
Number of subjects: 28
Study 8836300 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study 8836300 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-severe hypoglycemia group (non-SH group)
Number of subjects: 28
Study 1461472 — intervention group
Group type: EXPERIMENTAL
Intervention: propofol + fentanyl in air/O2
Number of subjects: 100
Study 1461472 — intervention group
Group type: EXPERIMENTAL
Intervention: isoflurane + fentanyl in air/O2
Number of subjects: 100
Study 1461472 — intervention group
Group type: EXPERIMENTAL
Intervention: propofol + fentanyl in N2O/O2
Number of subjects: 100
Study 1461472 — intervention group
Group type: EXPERIMENTAL
Intervention: isoflurane in N2O/O2
Number of subjects: 100
Study 3883739 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol-Verapamil (P-V)
Number of subjects: 19
Study 3883739 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol-Nifedipine (P-N)
Number of subjects: 19
Study 3883739 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol-Diltiazem (P-D)
Number of subjects: 19
Study 3883739 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 19
Study 29613975 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic therapy for late-onset sepsis
Number of subjects: 408
Study 29152839 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric bypass surgery (GB)
Number of subjects: 19
Study 29152839 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (CN)
Number of subjects: 19
Study 27128159 — intervention group
Group type: EXPERIMENTAL
Intervention: Media literacy education
Number of subjects: 472
Study 27128159 — intervention group
Group type: EXPERIMENTAL
Intervention: Need for cognition
Number of subjects: 472
Study 27128159 — intervention group
Group type: EXPERIMENTAL
Intervention: Need for affect
Number of subjects: 472
Study 24023271 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized action plans connecting patients to patient-assistance programs
Number of subjects: 374
Study 24023271 — intervention group
Group type: COMPARATOR
Intervention: Usual care (informational pamphlet)
Number of subjects: 374
Study 22004699 — intervention group
Group type: EXPERIMENTAL
Intervention: Type one tympanoplasty with anterior tagging
Number of subjects: 60
Study 22004699 — intervention group
Group type: COMPARATOR
Intervention: Type one tympanoplasty without anterior tagging
Number of subjects: 60
Study 20461009 — intervention group
Group type: EXPERIMENTAL
Intervention: Butyrate enema (100 mmol/l butyrate, 60 ml rectal enema, once daily for 2 weeks in healthy volunteers and 3 weeks in UC patients)
Number of subjects: 51
Study 20461009 — intervention group
Group type: COMPARATOR
Intervention: Placebo enema (60 ml rectal enema, once daily for 2 weeks in healthy volunteers and 3 weeks in UC patients)
Number of subjects: 51
Study 17606562 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical-intervention-plus-home-intervention group
Number of subjects: 130
Study 17606562 — intervention group
Group type: COMPARATOR
Intervention: Clinical-intervention-only group
Number of subjects: 130
Study 17606562 — intervention group
Group type: COMPARATOR
Intervention: Adequate-growth group
Number of subjects: 130
Study 17606562 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 130
Study 16123472 — intervention group
Group type: EXPERIMENTAL
Intervention: nateglinide/metformin
Number of subjects: 428
Study 16123472 — intervention group
Group type: COMPARATOR
Intervention: glyburide/metformin
Number of subjects: 428
Study 12373613 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly supplementation with iron (60 mg as ferrous sulphate) and folic acid (250 micro g) (n=121)
Number of subjects: 366
Study 12373613 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly supplementation with vitamin A (2400 RE) in addition to iron and folic acid (n=122)
Number of subjects: 366
Study 12373613 — intervention group
Group type: COMPARATOR
Intervention: Daily iron supplementation group (n=123)
Number of subjects: 366
Study 11223662 — intervention group
Group type: EXPERIMENTAL
Intervention: Echo-enhanced transcranial color-coded duplexsonography (TCCD)
Number of subjects: 30
Study 9599193 — intervention group
Group type: EXPERIMENTAL
Intervention: Antilymphocyte antibodies (induction therapy)
Number of subjects: 628
Study 7827444 — intervention group
Group type: EXPERIMENTAL
Intervention: Subzonal insemination (SUZI)
Number of subjects: 89
Study 7827444 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdroplet IVF
Number of subjects: 89
Study 7827444 — intervention group
Group type: COMPARATOR
Intervention: Standard IVF
Number of subjects: 89
Study 3280773 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic furosemide (1 mg/kg every 12 hours for four doses beginning at 24 hours of age)
Number of subjects: 0
Study 3280773 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic furosemide
Number of subjects: 0
Study 3280773 — intervention group
Group type: COMPARATOR
Intervention: prn use of furosemide
Number of subjects: 0
Study 31895407 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab therapy (200 mg every 3 weeks for a total of 18 doses)
Number of subjects: 1019
Study 31895407 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab therapy (with irAE)
Number of subjects: 1019
Study 31895407 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab therapy (after onset of irAE)
Number of subjects: 1019
Study 31895407 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1019
Study 31895407 — intervention group
Group type: COMPARATOR
Intervention: Placebo (before onset of irAE)
Number of subjects: 1019
Study 30180402 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (20-30 mg/(kg·d))
Number of subjects: 62
Study 30180402 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine A (3-5 mg/(kg·d))
Number of subjects: 62
Study 30180402 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil
Number of subjects: 62
Study 30180402 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine A
Number of subjects: 62
Study 28974902 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncut Roux‐en‐Y
Number of subjects: 158
Study 28974902 — intervention group
Group type: COMPARATOR
Intervention: Billroth II
Number of subjects: 158
Study 26551304 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel + Aspirin (n=84)
Number of subjects: 171
Study 26551304 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Aspirin (n=87)
Number of subjects: 171
Study 23638764 — intervention group
Group type: EXPERIMENTAL
Intervention: Listerine(®) Total Care
Number of subjects: 15
Study 23638764 — intervention group
Group type: COMPARATOR
Intervention: 22% hydro‐alcohol solution (negative control)
Number of subjects: 15
Study 23638764 — intervention group
Group type: COMPARATOR
Intervention: 0.2% chlorhexidine solution (positive control)
Number of subjects: 15
Study 21564106 — intervention group
Group type: EXPERIMENTAL
Intervention: New blood transfusion (less than 14 days old)
Number of subjects: 444
Study 21564106 — intervention group
Group type: COMPARATOR
Intervention: Old blood transfusion (more than 14 days old)
Number of subjects: 444
Study 21564106 — intervention group
Group type: COMPARATOR
Intervention: Any old blood transfusion
Number of subjects: 444
Study 21564106 — intervention group
Group type: COMPARATOR
Intervention: Old blood transfusion (1 unit)
Number of subjects: 444
Study 21564106 — intervention group
Group type: EXPERIMENTAL
Intervention: Each 1-day increase in storage of RBCs
Number of subjects: 444
Study 19177860 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen (40% inspired oxygen fraction through a face mask)
Number of subjects: 130
Study 19177860 — intervention group
Group type: COMPARATOR
Intervention: Room air
Number of subjects: 130
Study 19177860 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen
Number of subjects: 130
Study 17367032 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushtox
Number of subjects: 52
Study 17367032 — intervention group
Group type: EXPERIMENTAL
Intervention: Periogard
Number of subjects: 52
Study 17367032 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental solution (Cosmocil CQa and Myacide pharma BPa-based)
Number of subjects: 52
Study 17367032 — intervention group
Group type: COMPARATOR
Intervention: Sterile tap water (control)
Number of subjects: 52
Study 17367032 — intervention group
Group type: COMPARATOR
Intervention: In vitro (Periogard, Experimental solution, Brushtox, Sterile tap water)
Number of subjects: 52
Study 14622666 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 33
Study 14622666 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo TENS and pharmacologic analgesia alone)
Number of subjects: 33
Study 11303325 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg acetylsalicylic acid (aspirin) daily
Number of subjects: 53
Study 11303325 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg acetylsalicylic acid (aspirin) daily
Number of subjects: 53
Study 11303325 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg and 150 mg acetylsalicylic acid (aspirin) daily
Number of subjects: 53
Study 8972367 — intervention group
Group type: EXPERIMENTAL
Intervention: Test group with trephine sizing based on preoperative videokeratoscopy
Number of subjects: 18
Study 8972367 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study 8972367 — intervention group
Group type: EXPERIMENTAL
Intervention: Test group
Number of subjects: 18
Study 1463410 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser photocoagulation
Number of subjects: 32
Study 1463410 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 32
Study 31183985 — intervention group
Group type: EXPERIMENTAL
Intervention: Amorphous solid dispersion formulation
Number of subjects: 12
Study 31183985 — intervention group
Group type: COMPARATOR
Intervention: Nanocrystal formulation
Number of subjects: 12
Study 31183985 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast consumption (low-fat and high-fat)
Number of subjects: 12
Study 30517649 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR imaging order requisition indications
Number of subjects: 315
Study 30517649 — intervention group
Group type: EXPERIMENTAL
Intervention: Discrepancy between clinical information in requisitions and provider notes
Number of subjects: 315
Study 30517649 — intervention group
Group type: EXPERIMENTAL
Intervention: Kappa agreement among radiologists
Number of subjects: 315
Study 26597930 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS (n = 12)
Number of subjects: 20
Study 26597930 — intervention group
Group type: COMPARATOR
Intervention: Sham TMS (n = 8)
Number of subjects: 20
Study 25244489 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training
Number of subjects: 0
Study 25244489 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training + Aerobic exercise
Number of subjects: 0
Study 25244489 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercise
Number of subjects: 0
Study 22918011 — intervention group
Group type: EXPERIMENTAL
Intervention: Butorphanol 1 mg intramuscular
Number of subjects: 40
Study 22918011 — intervention group
Group type: COMPARATOR
Intervention: Tramadol 50 mg intramuscular
Number of subjects: 40
Study 21196805 — intervention group
Group type: EXPERIMENTAL
Intervention: Art-based leadership program
Number of subjects: 0
Study 21196805 — intervention group
Group type: COMPARATOR
Intervention: Conventional leadership program
Number of subjects: 0
Study 18081170 — intervention group
Group type: EXPERIMENTAL
Intervention: Clerkship structure with an academic attending, a third-year pediatric resident, and 4 third-year medical students, but no interns.
Number of subjects: 203
Study 18081170 — intervention group
Group type: COMPARATOR
Intervention: Traditional services (control group)
Number of subjects: 203
Study 17162861 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyanoacrylate tissue adhesive (CTA)
Number of subjects: 27
Study 17162861 — intervention group
Group type: COMPARATOR
Intervention: Suture
Number of subjects: 27
Study 11870337 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrant Soundbridge System (VSB)
Number of subjects: 53
Study 11870337 — intervention group
Group type: COMPARATOR
Intervention: Acoustic hearing aid
Number of subjects: 53
Study 10634122 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary approach (joint home visits)
Number of subjects: 47
Study 10634122 — intervention group
Group type: COMPARATOR
Intervention: Traditional approach (solo visits)
Number of subjects: 47
Study 10634122 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (joint home visits and solo visits)
Number of subjects: 47
Study 8610779 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose oxytocin
Number of subjects: 310
Study 8610779 — intervention group
Group type: COMPARATOR
Intervention: Low-dose oxytocin
Number of subjects: 310
Study 2125428 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl and diazepam (n = 30)
Number of subjects: 61
Study 2125428 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl alone (n = 31)
Number of subjects: 61
Study 2125428 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study 6252835 — intervention group
Group type: EXPERIMENTAL
Intervention: Mecillinam added to cefazolin and carbenicillin
Number of subjects: 0
Study 6252835 — intervention group
Group type: COMPARATOR
Intervention: Placebo added to cefazolin and carbenicillin
Number of subjects: 0
Study 30801481 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifampridine phosphate (30-80 mg/d divided into 3 or 4 doses daily)
Number of subjects: 26
Study 30801481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 28927270 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange juice
Number of subjects: 12
Study 28927270 — intervention group
Group type: EXPERIMENTAL
Intervention: Water
Number of subjects: 12
Study 28927270 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose (isocaloric beverage)
Number of subjects: 12
Study 26097441 — intervention group
Group type: EXPERIMENTAL
Intervention: L-citrulline (0.3 mM)
Number of subjects: 3
Study 26097441 — intervention group
Group type: EXPERIMENTAL
Intervention: GSH (1 mM)
Number of subjects: 3
Study 26097441 — intervention group
Group type: EXPERIMENTAL
Intervention: L-citrulline (500 mg/kg/day) + GSH (50 mg/kg/day)
Number of subjects: 3
Study 26097441 — intervention group
Group type: EXPERIMENTAL
Intervention: L-citrulline (2 g/day) + GSH (200 mg/day)
Number of subjects: 3
Study 26097441 — intervention group
Group type: COMPARATOR
Intervention: Cellulose placebo (2.52 g/day)
Number of subjects: 3
Study 24862633 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic radical cystectomy (RARC)
Number of subjects: 40
Study 24862633 — intervention group
Group type: COMPARATOR
Intervention: Open radical cystectomy (ORC)
Number of subjects: 40
Study 22401726 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosomatic approach program (10 sessions, one/week for 2 hours and 15 minutes, with phone calls between sessions)
Number of subjects: 184
Study 22401726 — intervention group
Group type: COMPARATOR
Intervention: Usual program of the health center (8-10 weekly sessions of 2 hours, no phone calls)
Number of subjects: 184
Study 22401726 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosomatic approach program
Number of subjects: 184
Study 22401726 — intervention group
Group type: COMPARATOR
Intervention: Usual program of the health center
Number of subjects: 184
Study 19733719 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin therapy
Number of subjects: 2928
Study 17419798 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intervention including a nutritional journal and protein-enriched meals for at least four days postoperatively, plus at least two nutritional and protein drinks served each day during hospitalization.
Number of subjects: 157
Study 17419798 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 157
Study 14747185 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysterectomy
Number of subjects: 236
Study 14747185 — intervention group
Group type: COMPARATOR
Intervention: LNG-IUS
Number of subjects: 236
Study 11499327 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene 0.1% gel applied on alternate days for 15 weeks
Number of subjects: 164
Study 11499327 — intervention group
Group type: COMPARATOR
Intervention: Adapalene 0.1% gel applied once daily for 15 weeks
Number of subjects: 164
Study 11499327 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene 0.1% gel applied on alternate days
Number of subjects: 164
Study 11499327 — intervention group
Group type: COMPARATOR
Intervention: Adapalene 0.1% gel applied once daily
Number of subjects: 164
Study 10212375 — intervention group
Group type: EXPERIMENTAL
Intervention: Visomat OZ2 (upper arm)
Number of subjects: 85
Study 10212375 — intervention group
Group type: EXPERIMENTAL
Intervention: Omron R3 (wrist)
Number of subjects: 85
Study 10212375 — intervention group
Group type: COMPARATOR
Intervention: Sphygmomanometer (control)
Number of subjects: 85
Study 10212375 — intervention group
Group type: EXPERIMENTAL
Intervention: Oscillometric blood pressure monitors (upper arm and wrist)
Number of subjects: 85
Study 8163757 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous flecainide (2 mg/kg for 10 min and continuous perfusion of 1.5 mg/kg for 1 h)
Number of subjects: 30
Study 8163757 — intervention group
Group type: COMPARATOR
Intervention: Intravenous verapamil (0.15 mg/kg for 5 min and continuous perfusion of 0.005 mg/kg/min for 1 h)
Number of subjects: 30
Study 3147191 — intervention group
Group type: EXPERIMENTAL
Intervention: 58 different fat-modified diets
Number of subjects: 130
Study 3147191 — intervention group
Group type: EXPERIMENTAL
Intervention: fat-modified diets
Number of subjects: 130
Study 31747095 — intervention group
Group type: EXPERIMENTAL
Intervention: DCEAS+BA
Number of subjects: 91
Study 31747095 — intervention group
Group type: COMPARATOR
Intervention: Minimum acupuncture stimulation (MAS)
Number of subjects: 91
Study 30985642 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral intervention
Number of subjects: 55
Study 30985642 — intervention group
Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 55
Study 28154256 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal dexmedetomidine (5 µg)
Number of subjects: 90
Study 28154256 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal dexmedetomidine (2.5 µg)
Number of subjects: 90
Study 28154256 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (control)
Number of subjects: 90
Study 25886041 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop control of propofol
Number of subjects: 180
Study 25886041 — intervention group
Group type: COMPARATOR
Intervention: Opened-loop control of propofol
Number of subjects: 180
Study 24006857 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted lifestyle intervention consisting of 10 group counseling sessions focusing on diet, physical activity, and behavioral change over 6 months, including gender-specific exercise sessions and counseling by a health coach community member.
Number of subjects: 308
Study 24006857 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving information about healthy lifestyle habits provided by the primary health care center.
Number of subjects: 308
Study 24006857 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted lifestyle intervention
Number of subjects: 308
Study 21309858 — intervention group
Group type: EXPERIMENTAL
Intervention: Deprotenized bovine bone mineral (DBBM) and collagen barrier membranes (CM)
Number of subjects: 22
Study 21309858 — intervention group
Group type: COMPARATOR
Intervention: Mandibular blocks (control group)
Number of subjects: 22
Study 19167814 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (opioid antagonist)
Number of subjects: 55
Study 19167814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 16388879 — intervention group
Group type: EXPERIMENTAL
Intervention: FMP1/AS02A vaccine
Number of subjects: 40
Study 16388879 — intervention group
Group type: COMPARATOR
Intervention: Imovax rabies vaccine
Number of subjects: 40
Study 16366195 — intervention group
Group type: EXPERIMENTAL
Intervention: Itone drops (herbal eye drop)
Number of subjects: 120
Study 16366195 — intervention group
Group type: COMPARATOR
Intervention: Tears substitute (tears plus)
Number of subjects: 120